Business Wire

TN-NASHVILLE-SOCCER-CLUB

Share
Filip Forsberg, Giannis Antetokounmpo Join Nashville Soccer Club Ownership Group

As Nashville Soccer Club enters its fourth season in Major League Soccer, and second at GEODIS Park, principal owner John Ingram announced today that leading scorer in Nashville Predator history Filip Forsberg and two-time MVP and NBA Champion Giannis Antetokounmpo have joined the team’s ownership group.

Antetokounmpo is joined in ownership by his brothers Thanasis, Kostas and Alex as well – all of whom play professional basketball worldwide. Thanasis joined Giannis in winning the NBA Championship with the Milwaukee Bucks in 2021, and Kostas won one with the Los Angeles Lakers in 2020.

The announcement of the new owners continues the strong momentum built by Nashville SC in the lead-up to the 2023 season, highlighted by its 'Man in Black’ jersey collaboration with the Estate of Johnny Cash. That momentum continued with a 2-0 victory over New York City FC in front of 28,051 fans at GEODIS Park this past Saturday.

Forsberg and Antetokounmpo join a robust and diverse ownership group whose most recent additions include Reese Witherspoon, her husband Jim Toth and Derrick Henry.

“Nashville is the best sports city in the country, and I am extremely blessed to now be involved with two of our pro teams,” said Forsberg. “Our city is one big family and fanbase, and we support each other on and off the field. Nashville SC has been such a great addition to our sports culture, and joining the ownership group was an opportunity I wasn’t going to pass up. I grew up a Liverpool FC fan in Sweden, and after today I am happy to add a second set of colors to cheer for!”

“My father was a professional soccer player, and it was the first sport I fell in love with in Greece,” said Antetokounmpo. “I’ve always had the dream of owning a soccer team. When my brothers and I explored Nashville SC, we knew it was a team and a city that we wanted to get involved with. I couldn’t be more excited to join the Boys in Gold, and can’t wait to come to a match at GEODIS Park soon!”

“Soccer is a global sport, and our newest owners once again reinforce our club’s commitment to being a global team,” said Ingram. “Filip and Giannis are not just amazing athletes – they are ambassadors for their respective sports, role models for millions and advocates in their hometowns and worldwide. We share a common belief that our teams not only play to the highest standards, but also lift up their communities and help those who need it most.”

Nashville SC takes on the road to face the New York Red Bulls at 6:30 p.m. CT on Saturday, March 4. Fans ns can follow the action on the MLS Season Pass on the Apple TV app and the club on its digital and social channels on Instagram, Facebook, TikTok, Twitter and Spotify.

MEDIA RESOURCES:

  • Nashville SC Media Center with news, b-roll from training, match notes, other video and photo resources
  • Media looking to follow NSC on social media can find the club on TikTok, Twitter and Instagram with the handle @NashvilleSC. For Facebook and YouTube please use “Nashville Soccer Club”
  • The official club hashtag when referring to Nashville SC on social media is #EveryoneN

FOR MORE INFORMATION, CONTACT: Zach Hunt, zach@tsgnashville.com, 615.321.3110.

About Nashville SC

Nashville SC joined Major League Soccer on Feb. 29, 2020 in front of the largest attendance ever recorded for a soccer match in the State of Tennessee. In its inaugural MLS season, Nashville SC defeated expectations by becoming the second MLS expansion side to win and advance to the Conference Semifinals in the 2020 Audi MLS Cup Playoffs. Nashville SC returned to the 2021 Audi MLS Cup Playoffs in its sophomore season after becoming just the seventh team in MLS history to go unbeaten at home in a season. Nashville SC inaugurated GEODIS Park, the largest soccer-specific stadium in the United States and Canada, in front of a 30,109-sellout crowd on May 1, 2022. For more information, visit NashvilleSC.com and follow the club at @NashvilleSC on Instagram, Facebook, Twitter and Spotify.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230302005537/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye